Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Apr;40(1):184–189. doi: 10.1128/iai.40.1.184-189.1983

Detection of type-specific antibody to herpes simplex virus type 1 by radioimmunoassay with herpes simplex virus type 1 glycoprotein C purified with monoclonal antibody.

A M Arvin, C M Koropchak, A S Yeager, L Pereira
PMCID: PMC264834  PMID: 6832831

Abstract

Herpes simplex virus type 1 (HSV-1) and HSV-2 specify at least four glycoproteins designated gA/gB, gC, gD, and gE. Previous studies have shown that gC produced by HSV-1 is antigenically distinct from the corresponding HSV-2 glycoprotein. With the exception of gC, the glycoproteins of both serotypes share antigenic sites. Standard serological assays fail to differentiate the antibody to the shared antigenic determinants from the type-specific antibody. In this paper, we describe a procedure for purifying gC from HSV-1-infected cell extracts with an immunoadsorbent prepared with an HCL monoclonal antibody. When used in a solid-phase radioimmunoassay, gC proved to be a type-specific antigen for quantitation of antibody to HSV-1. Among individuals who had no antibody to HSV at the onset of infection, all of those with primary HSV-1 infection developed antibody to gC. Subjects with primary HSV-2 infection failed to develop antibody reactive with gC of HSV-1 (P less than 0.01). Both immunoglobulin G and M antibodies against gC were detected in sera from subjects with either primary or recurrent HSV-1 infection. Higher antibody titers to gC were found in sera from individuals with recurrent infection than in sera from those with primary HSV-1 infection.

Full text

PDF
186

Images in this article

186Image
on p.186

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buchman T. G., Roizman B., Adams G., Stover B. H. Restriction endonuclease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak. J Infect Dis. 1978 Oct;138(4):488–498. doi: 10.1093/infdis/138.4.488. [DOI] [PubMed] [Google Scholar]
  2. Cohen G. H., Katze M., Hydrean-Stern C., Eisenberg R. J. Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein. J Virol. 1978 Jul;27(1):172–181. doi: 10.1128/jvi.27.1.172-181.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dix R. D., Pereira L., Baringer J. R. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect Immun. 1981 Oct;34(1):192–199. doi: 10.1128/iai.34.1.192-199.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dreesman G. R., Matson D. O., Courtney R. J., Adam E., Melnick J. L. Detection of herpesvirus type-specific antibody by a micro solid phase radioimmunometric assay. Intervirology. 1979;12(2):115–119. doi: 10.1159/000149077. [DOI] [PubMed] [Google Scholar]
  5. Eberle R., Courtney R. J. Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human sera. Infect Immun. 1981 Mar;31(3):1062–1070. doi: 10.1128/iai.31.3.1062-1070.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eisenberg R. J., Ponce de Leon M., Pereira L., Long D., Cohen G. H. Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody. J Virol. 1982 Mar;41(3):1099–1104. doi: 10.1128/jvi.41.3.1099-1104.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Forghani B., Schmidt N. J., Lennette E. H. Solid phase radioimmunoassay for typing herpes simplex viral antibodies in human sera. J Clin Microbiol. 1975 Nov;2(5):410–418. doi: 10.1128/jcm.2.5.410-418.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Heine J. W., Spear P. G., Roizman B. Proteins specified by herpes simplex virus. VI. Viral proteins in the plasma membrane. J Virol. 1972 Mar;9(3):431–439. doi: 10.1128/jvi.9.3.431-439.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hilleman M. R. Herpes simplex vaccines. Cancer Res. 1976 Feb;36(2 Pt 2):857–858. [PubMed] [Google Scholar]
  10. Johnson L. D., Fuccillo D. A., Stalder H., Oxman M. A., Fraser C. E., Madden D. L. Comparison of indirect hemagglutination and indirect immunofluorescence tests with microneutralization tests for detection of type-specific Herpesvirus hominis antibody. J Clin Microbiol. 1979 Mar;9(3):384–390. doi: 10.1128/jcm.9.3.384-390.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Morse L. S., Pereira L., Roizman B., Schaffer P. A. Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants. J Virol. 1978 May;26(2):389–410. doi: 10.1128/jvi.26.2.389-410.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Norrild B. Immunochemistry of herpes simplex virus glycoproteins. Curr Top Microbiol Immunol. 1980;90:67–106. doi: 10.1007/978-3-642-67717-5_4. [DOI] [PubMed] [Google Scholar]
  13. Para M. F., Goldstein L., Spear P. G. Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein. J Virol. 1982 Jan;41(1):137–144. doi: 10.1128/jvi.41.1.137-144.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pereira L., Dondero D. V., Gallo D., Devlin V., Woodie J. D. Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies. Infect Immun. 1982 Jan;35(1):363–367. doi: 10.1128/iai.35.1.363-367.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pereira L., Dondero D., Norrild B., Roizman B. Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5202–5206. doi: 10.1073/pnas.78.8.5202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pereira L., Klassen T., Baringer J. R. Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Infect Immun. 1980 Aug;29(2):724–732. doi: 10.1128/iai.29.2.724-732.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Savage T., Roizman B., Heine J. W. Immunological specificity of the glycoproteins of herpes simplex virus subtypes 1 and 2. J Gen Virol. 1972 Oct;17(1):31–48. doi: 10.1099/0022-1317-17-1-31. [DOI] [PubMed] [Google Scholar]
  18. Sim C., Watson D. H. The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2. J Gen Virol. 1973 May;19(2):217–233. doi: 10.1099/0022-1317-19-2-217. [DOI] [PubMed] [Google Scholar]
  19. Spear P. G. Glycoproteins specified by herpes simplex virus type 1: their synthesis, processing and antigenic relatedness to HSV -2 glycoproteins. IARC Sci Publ. 1975;(11 Pt 1):49–61. [PubMed] [Google Scholar]
  20. Vestergaard B. F. Quantitative immunoelectrophoretic analysis of human antibodies against herpes simplex virus antigens. Infect Immun. 1979 Mar;23(3):553–558. doi: 10.1128/iai.23.3.553-558.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yeager A. S., Arvin A. M., Urbani L. J., Kemp J. A., 3rd Relationship of antibody to outcome in neonatal herpes simplex virus infections. Infect Immun. 1980 Aug;29(2):532–538. doi: 10.1128/iai.29.2.532-538.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Zweerink H. J., Corey L. Virus-specific antibodies in sera from patients with genital herpes simplex virus infection. Infect Immun. 1982 Aug;37(2):413–421. doi: 10.1128/iai.37.2.413-421.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES